Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The New Economy and its Winners -- Ignore unavailable to you. Want to Upgrade?

To: Tom Kearney who wrote (26901)	1/15/2006 12:03:01 AM
From: Lizzie Tudor	Read Replies (3) \| Respond to of 57684

emergencies have to happen here of course. But nothing else. Lots of healthcare "breakthroughs" are targeted at vanity surgery too, face lifts and reconstruction after surgery (which is not always vanity, I know). But anyway that is a lot of elective surgery and people are going overseas for that. A few mos ago I took a look at one of those stock screeners, and I was amazed at the number of DRUG COMPANIES that have market caps over 20billion. Way more than any other group. More than tech, semiconductor etc. The reason the valuation on these companies is so high is that they are benefitting from our health care "system" such as it is. I just don't think the system is working and I don't think it can be maintained and therfore I don't believe ISRG and FOXH are going to be rewarded multi billion dollar mkt caps in the future. How many of these devices do these companies actually sell? Not many. Medical devices have a limited market to sell into. If these companies sell into the US hospital system, well, hard not to see serious price erosion coming. jmo.